UKAD 2015 UKAD vs Gareth Warburton

Facts
The United Kingdom Anti-Doping (UKAD) had charged Garath Warburton, the athlete, for a violation of the Anti-Doping Rules. On June 17, 2014, during an out-of-competition doping control samples were taken for doping test purposes. The samples of the athlete showed the presence of a metabolite of several exogenous anabolic steroids including methyltestosterone and metandienone. These exogenous steroids are prohibited substances according the World Anti-Doping Agency (WADA) 2014 prohibited list.

History
The Athlete didn't knew that the supplement he had used was contaminated with the prohibited substance and requested that any sanction will be eliminated. The athlete personally investigated the supplements and the need to make all necessary inquiries as to their safety”. He researched the suppliers website and undertook appropriate additional investigations, including that the products were backed by certificates of conformity, indicating to him that they were properly batch tested and safe to use. Further, he discussed it with his agent, and his partner and colleagues. No one said it was anything other than ‘safe’ to use.
Because of the fact that his sanction was reached after January 1, 2015 Lex mitior was applied because the new ruling of the WADA has a lesser severe penalty for this violation.

Decision
The period of Ineligibility imposed is six months commencing on 11 July 2014.

Original document

Parameters

Legal Source
National Decisions
Date
12 January 2015
Arbitrator
Murdock, Colin
O'Driscoll, Barry
Quinlan, Christopher
Original Source
UK Anti-Doping (UKAD)
Country
United Kingdom
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Lex mitior
No Significant Fault or Negligence
Period of ineligibility
Sport/IFs
Athletics (WA) - World Athletics
Other organisations
UK Anti-Doping (UKAD)
UK Athletics
Laboratories
London, United Kingdom: Drug Control Centre
Analytical aspects
B sample analysis
Doping classes
S1. Anabolic Agents
Substances
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Methyltestosterone
Various
Contamination
Supplements
Document type
Pdf file
Date generated
3 June 2015
Date of last modification
21 June 2021
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin